Health Care; Pharmaceutical; Diagnostic; Biotech; Chemical; Manufacturing; Medical Device; Consumer Products
abbott; GlaxoSmithKline; Genzyme; Ipsen; Celgene; Xanodyne Pharmaceuticals; Astellas; Ther-Rx; Bristol-Myers Squibb; Amylin; MSD; Hospira; RECKITT BENCKISER; Genentech; Roche; Sandoz; Merck; Bayer
This report explore best practices in the use and management of physician e-sampling as a means “to obtain access” to prescribing physicians. The report benchmarks how pharmaceutical companies organize their sampling efforts and explores the alignment of activities with specific goals for these approaches, such as the percentage of physicians served through physician e-sampling, volume of samples direct shipped, sampling methods (direct orders, vouchers, etc.), peripheral activities (e.g., physician signatures, temperature monitoring), budgets, and performance metrics.
The report also offers broader qualitative insights into the trends, successes, and pitfalls associated with these efforts as well as strategic implications for physician access and other elements of the commercial model.